Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer

NCT02848872 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT02848872
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02848872 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Tumor and Blood Immune Biomarkers in Resected Non-small Cell Lung Cancer
Lead sponsor
Duke University
Phase
Observational
Overall status
Completed
Start date
May 31, 2016
Completion date
April 2, 2019
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung carcinoma